Adding Vitamin E-TPGS to the Formulation of Genexol-PM: Specially Mixed Micelles Improve Drug-Loading Ability and Cytotoxicity against Multidrug-Resistant Tumors Significantly

被引:38
作者
Fan, Zhuoyang [1 ]
Chen, Cheng [1 ]
Pang, Xiaoying [1 ]
Yu, Zhou [1 ]
Qi, Yang [1 ]
Chen, Xinyi [1 ]
Liang, Huihui [1 ]
Fang, Xiaoling [1 ]
Sha, Xianyi [1 ]
机构
[1] Fudan Univ, Sch Pharm, Dept Pharmaceut, Minist Educ & PLA,Key Lab Smart Drug Delivery, Shanghai 201203, Peoples R China
来源
PLOS ONE | 2015年 / 10卷 / 04期
基金
中国国家自然科学基金;
关键词
CELL LUNG-CANCER; PHASE-II; COPOLYMER MICELLES; CREMOPHOR-FREE; IN-VITRO; PACLITAXEL; DELIVERY; GLYCOPROTEIN; PHARMACOKINETICS; BIODISTRIBUTION;
D O I
10.1371/journal.pone.0120129
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Genexol-PM, produced by Samyang Company (Korea) is an excellent preparation of paclitaxel (PTX) for clinical cancer treatment. However, it cannot resolve the issue of multidrug resistance (MDR)-a significant problem in the administration of PTX to cancer patients. To increase the efficacy of Genexol-PM against MDR tumors, a mixed micelle capable of serving as a vehicle for PTX was developed, and two substances were chosen as carrier materials: 1) Polyethylene glycol-polylactic acid (PEG-PLA), the original vehicle of Genexol-PM. 2) Vitamin E-TPGS, an inhibitor of P-glycoprotein (P-gp). P-gp has been proven to be the main cause of MDR. In vitro evaluation indicated that the mixed micelle was an ideal PTX delivery system for the treatment of MDR tumors; the mixed micelle also showed a significantly better drug-loading coefficient than Genexol-PM.
引用
收藏
页数:17
相关论文
共 38 条
[1]   Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications [J].
Berger, W ;
Setinek, U ;
Hollaus, P ;
Zidek, T ;
Steiner, E ;
Elbling, L ;
Cantonati, H ;
Attems, J ;
Gsur, A ;
Micksche, M .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (06) :355-363
[2]   ABSORPTION, TRANSPORT AND DISTRIBUTION OF VITAMIN-E [J].
BJORNEBOE, A ;
BJORNEBOE, GEA ;
DREVON, CA .
JOURNAL OF NUTRITION, 1990, 120 (03) :233-242
[3]   Multidrug resistance ABC transporters [J].
Chang, G .
FEBS LETTERS, 2003, 555 (01) :102-105
[4]   Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation [J].
Chen, Liangcen ;
Sha, Xianyi ;
Jiang, Xinyi ;
Chen, Yanzuo ;
Ren, Qiuyue ;
Fang, Xiaoling .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2013, 8 :73-84
[5]   Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS:: Influence on ATPase activity and membrane fluidity [J].
Collnot, Eva-Maria ;
Baldes, Christiane ;
Wempe, Michael F. ;
Kappl, Reinhard ;
Huettermann, Juergen ;
Hyatt, John A. ;
Edgar, Kevin J. ;
Schaefer, Ulrich F. ;
Lehr, Claus-Michael .
MOLECULAR PHARMACEUTICS, 2007, 4 (03) :465-474
[6]   Vitamin E TPGS P-Glycoprotein Inhibition Mechanism: Influence on Conformational Flexibility, Intracellular ATP Levels, and Role of Time and Site of Access [J].
Collnot, Eva-Maria ;
Baldes, Christiane ;
Schaefer, Ulrich F. ;
Edgar, Kevin J. ;
Wempe, Michael F. ;
Lehr, Claus-Michael .
MOLECULAR PHARMACEUTICS, 2010, 7 (03) :642-651
[7]  
Filipits M., 2004, DRUG DISCOV TODAY, V1, P229, DOI [DOI 10.1016/J.DDMEC.2004.10.001, 10.1016/j.ddmec.2004.10.001]
[8]   DIODE-ARRAY UV SPECTROMETRIC EVIDENCE FOR A CONCENTRATION-DEPENDENT PHASE-TRANSITION IN DILUTE AQUEOUS-SOLUTIONS OF PLURONIC F87 (POLOXAMER-237) [J].
GAISFORD, S ;
BEEZER, AE ;
MITCHELL, JC ;
LOH, W ;
FINNIE, JK ;
WILLIAMS, SJ .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1995, (18) :1843-1844
[9]   Diode-array UV spectrometric evidence for cooperative interactions in binary mixtures of Pluronics F77, F87, and F127 [J].
Gaisford, S ;
Beezer, AE ;
Mitchell, JC .
LANGMUIR, 1997, 13 (10) :2606-2607
[10]   Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with pluronic P123 [J].
Han, Li-Mei ;
Guo, Jie ;
Zhang, Li-Jun ;
Wang, Qing-Song ;
Fang, Xiao-Ling .
ACTA PHARMACOLOGICA SINICA, 2006, 27 (06) :747-753